Cyrano Therapeutics, a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss, and Resyca, a leading innovator in soft mist inhaler and soft nasal spray ...

Kenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.

The Grossman Group, a Chicago-based leadership and communications consultancy celebrating its 25th anniversary this month, has been named a finalist for Best Small Agency in the Public Relations ...

The company, established in 2018 and based in the US state of New Jersey, focuses on pharma aerosol product development, which includes a range of inhalers and sprays. These encompass soft mist ...

Event Tickets Center, the trusted marketplace for live event tickets that connects fans with unforgettable live experiences, and Peoria Sports Complex, the spring training home of the Seattle Mariners ...

And while other options exist like dry-powder inhalers and soft mist inhalers, MDIs are still the best option for many patients for a variety of reasons, according to AstraZeneca. AstraZeneca and ...

About Kenox Pharmaceuticals Inc.: Established in 2018 and based in the greater Princeton area, NJ, Kenox specializes in pharmaceutical aerosol product development, including soft mist inhalers ...

According to an article in the New England Journal of Medicine, other options can be used, including dry powder and soft-mist inhalers, but they are unsuitable for young children and frail adults.

ERS Interferon-β Curbs Cold-Induced Asthma Exacerbations In a placebo-controlled trial, interferon-β significantly decreased cold-induced exacerbations in patients with difficult-to-treat asthma ...